Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01793974 · ClinicalTrials.gov registry record
Genetics of Latent Autoimmune Diabetes in Adults
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 205
- Enrollment target
NCT01793974: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT01793974 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 205 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01793974 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
Study Summary
This is a prospective study that will study adults and has the objective of examining 'Latent Autoimmune Diabetes in Adults' (LADA) to understand how this trait is influenced by genetic factors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-03 |
What the finished NCT01793974 record still lists
NCT01793974 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01793974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01793974 about?
NCT01793974 is a clinical study titled "Genetics of Latent Autoimmune Diabetes in Adults". This is a prospective study that will study adults and has the objective of examining 'Latent Autoimmune Diabetes in Adults' (LADA) to understand how this trait is influenced by genetic factors.
What is the current status of trial NCT01793974?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2011-07. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT01793974?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia